Medication info
Teneligliptin Extended-Release Tablets 20/1000 mg

Teneligliptin Extended-Release Tablets 20/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›26mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Nexpharm Korea Co., Ltd.
Appearance
Pink oval-shaped extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201494 · Approved 2022.04.08 · Insurance code 662504780

Summary

Main use
Improves blood glucose control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one tablet of this medicine 20/1000mg extended-release once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release should take 2 tablets together once daily. In patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's existing dose of metformin. In patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be started at the existing doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, blood glucose control should be closely monitored and the dose adjusted appropriately. When coadministered with a sulfonylurea, reducing the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other glucose-lowering medicines. Because a change in blood glucose control may occur, any change in treatment for patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, this medicine should be swallowed whole and not split, crushed, ground, or chewed.

Ingredients

Manufacturer
Nexpharm Korea Co., Ltd.

Efficacy & effects

Improves blood glucose control in patients with type 2 diabetes

View approved original text

This medication is administered as an adjunct to improve blood glucose control in patients with type 2 diabetes in conjunction with dietary control and exercise therapy using Teneligliptin and Metformin together.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one tablet of this medicine 20/1000mg extended-release once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release should take 2 tablets together once daily. In patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's existing dose of metformin. In patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be started at the existing doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, blood glucose control should be closely monitored and the dose adjusted appropriately. When coadministered with a sulfonylurea, reducing the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other glucose-lowering medicines. Because a change in blood glucose control may occur, any change in treatment for patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, this medicine should be swallowed whole and not split, crushed, ground, or chewed.

Precautions

This medication may cause a rare side effect called severe lactic acidosis, so it should not be used in patients with impaired kidney function or those with heart disease. Hypoglycemia may occur if taken in conjunction with other diabetes medications, so patients should be well aware of hypoglycemic symptoms. This drug should not be administered to patients with moderate to severe renal impairment, heart failure, or acute kidney disease. Patients planning to undergo examinations using radiologic contrast agents should stop taking this medication 48 hours prior to the examination and resume only after normal kidney function is confirmed. Women who are pregnant or may become pregnant are advised not to take this medication. Patients with impaired liver function, severe lung disease, heavy alcohol consumption, dehydration, or gastrointestinal disorders should also use this medication with caution. This drug may cause hypoglycemia, so patients taking it alongside insulin or sulfonylurea medications should regularly check their blood glucose levels and be attentive to symptoms. If symptoms of acute pancreatitis such as severe abdominal pain or vomiting occur, consult a doctor immediately. Should symptoms of intestinal obstruction arise, discontinue use and seek medical attention. This medication can lower vitamin B12 levels, necessitating regular blood tests, and if symptoms of vitamin B12 deficiency appear, appropriate measures should be taken. Elderly patients may have decreased kidney function, so renal function should be tested regularly and dose adjustments may be necessary. Alcohol consumption can increase the risk of lactic acidosis, so drinking should be avoided while taking this medication. In situations such as surgery, severe infections, or trauma, this medication should be temporarily discontinued and resumed only after the condition improves. Notify your doctor immediately if any skin blisters or abnormalities occur during the use of this medication. In case of overdose, visit a medical institution immediately for appropriate treatment, and blood dialysis may be performed if necessary. Keep out of reach of children, and do not transfer to another container.

Side effects

  • Severe lactic acidosis
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • pseudoporphyria
  • acute pancreatitis
  • dizziness
  • abdominal distension
Show 155 more
  • abdominal discomfort
  • nausea
  • abdominal pain
  • abdominal bloating
  • stomatitis
  • gastric polyps
  • colonic polyps
  • duodenal ulcers
  • gastroesophageal reflux disease
  • diarrhea
  • decreased appetite
  • elevated amylase
  • elevated lipase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • elevated GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • elevated CK (CPK)
  • increased serum potassium concentration
  • lethargy
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • shingles
  • limb pain
  • upper abdominal pain
  • gastritis
  • upper respiratory infection
  • tremors
  • headache
  • weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • cold sweat
  • pruritus
  • diabetic retinopathy
  • vision decrease
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • decreased neutrophil count
  • abnormal blood sugar
  • increased blood sugar
  • increased blood pressure
  • hepatic encephalopathy
  • lumbar spinal canal stenosis
  • intervertebral disc protrusion
  • intervertebral disc disruption
  • spinal ligament ossification
  • lumbar foramen stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureterolithiasis
  • urolithiasis
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • biliary obstruction
  • chronic cholecystitis
  • soft tissue inflammation
  • pneumonia
  • cataract
  • depression
  • iliac artery stenosis
  • dizziness
  • benign prostatic hyperplasia
  • knee surgery
  • dizziness
  • diabetic neuropathy
  • sensory abnormalities
  • muscle weakness
  • back pain
  • limb pain
  • tendonitis
  • cervical pain
  • bone pain
  • osteoarthritis
  • osteoporosis
  • muscle cramps
  • foot deformities
  • hypertrophic osteoarthropathy
  • bursitis
  • spinal osteoarthritis
  • postmenopausal osteoporosis
  • chronic gastritis
  • irritable bowel syndrome
  • vomiting
  • abdominal pain
  • gastrointestinal motility disorders
  • decreased gastrointestinal motility
  • enteritis
  • dental pain
  • anal rectal discomfort
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • bleeding
  • abnormal sputum
  • dyspnea
  • acute dyspnea
  • atelectasis
  • nasal bleeding
  • chest discomfort
  • fever
  • chills
  • generalized edema
  • injection site inflammation
  • dysuria
  • renal cysts
  • nocturia
  • ovarian cysts
  • vulvar pruritus
  • menopausal symptoms
  • toxic hepatitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid injury
  • ligament sprain
  • lip injury
  • bruise
  • urticaria
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • angina
  • otalgia
  • iron deficiency anemia
  • food allergy
  • pressure sore ulcer

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air and moisture exposure, and kept at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness and prevent deterioration.

Appearance and packaging

Appearance

Pink oval-shaped extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.